Rockefeller Capital Management L.P. Castle Biosciences Inc Transaction History

Rockefeller Capital Management L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 06, 2023	BUY	$18.08 - $30.0 $2,784 - $4,620	154 Added 3.72%	4,294 $101,000
Q3 2022 Nov 02, 2022	BUY	$22.51 - $34.32 $88,689 - $135,220	3,940 Added 1970.0%	4,140 $107,000
Q2 2022 Aug 12, 2022	SELL	$16.0 - $45.99 $352 - $1,011	-22 Reduced 9.91%	200 $4,000
Q1 2022 May 13, 2022	BUY	$33.17 - $46.98 $729 - $1,033	22 Added 11.0%	222 $9,000
Q2 2021 Aug 10, 2021	SELL	$50.07 - $76.78 $50 - $76	-1 Reduced 0.5%	200 $14,000
Q1 2021 May 11, 2021	BUY	$58.92 - $97.33 $11,842 - $19,563	201 New	201 $13,000

201

24.4M

303K

30.3K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $723M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.